Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Aroa Biosurgery Ltd (ARX) vs. Competitors

64 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:ARXAroa Biosurgery LtdAUD 0.50AUD 176.20M41.67-36.54%Moderate BuyUnlock the AU:ARX analyst price target with TipRanks PremiumAU:ARXUnlock the AU:ARX top-analyst price target with TipRanks Premium
AU:PNVPolynovo AUD 0.91AUD 611.40M84.91-26.12%Strong BuyUnlock the AU:PNV analyst price target with TipRanks PremiumAU:ARX vs AU:PNVUnlock the AU:PNV top-analyst price target with TipRanks Premium
AU:COHCochlear AUD 150.72AUD 9.97B68.49-47.74%HoldUnlock the AU:COH analyst price target with TipRanks PremiumAU:ARX vs AU:COHUnlock the AU:COH top-analyst price target with TipRanks Premium
AU:IPDImpedimed LimitedAUD 0.00AUD 14.66M-0.34-64.10%Moderate BuyUnlock the AU:IPD analyst price target with TipRanks PremiumAU:ARX vs AU:IPDUnlock the AU:IPD top-analyst price target with TipRanks Premium
AU:OSLOncoSil Medical LtdAUD 0.67AUD 25.33M-1.36-50.45%―Unlock the AU:OSL analyst price target with TipRanks PremiumAU:ARX vs AU:OSLUnlock the AU:OSL top-analyst price target with TipRanks Premium
AU:EBREBR Systems, Inc. Shs Chess Depository Interests Repr 1 ShAUD 0.17AUD 139.50M-1.24-84.47%Strong BuyUnlock the AU:EBR analyst price target with TipRanks PremiumAU:ARX vs AU:EBRUnlock the AU:EBR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-75%-50%-25%0%25%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:ARXAroa Biosurgery Ltd0.49-0.28-35.71%
AU:PNVPolynovo 0.91-0.33-27.02%
AU:COHCochlear 150.72-129.67-46.25%
AU:IPDImpedimed Limited0.01-0.02-62.16%
AU:OSLOncoSil Medical Ltd0.67-0.64-48.92%
AU:EBREBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh0.17-0.94-84.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts